Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patients.
Pereira DS, Maturi RK, Akita K, Mahesh V, Bhisitkul RB, Nishihata T, Sakota E, Ali Y, Nakamura E, Bezwada P, Nakamura Y. Pereira DS, et al. Among authors: maturi rk. Eye (Lond). 2024 Apr;38(6):1140-1148. doi: 10.1038/s41433-023-02848-7. Epub 2023 Nov 30. Eye (Lond). 2024. PMID: 38036609 Free PMC article. Clinical Trial.
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40.
Jhaveri CD, Liu D, Maguire MG, Glassman AR, Grigorian RA, Jampol LM, Kingsley RM, MacCumber MW, Martin DF, Maturi RK, Velez G, Sun JK; DRCR Retina Network. Jhaveri CD, et al. Among authors: maturi rk. Ophthalmology. 2024 Feb 8:S0161-6420(24)00098-8. doi: 10.1016/j.ophtha.2024.01.037. Online ahead of print. Ophthalmology. 2024. PMID: 38336282
Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results.
Callanan D, Khurana RN, Maturi RK, Patel S, Wykoff CC, Eichenbaum D, Khanani AM, Hassan T, Badger H, Mehta S, Le G, Attar M, Seal J, Li XY. Callanan D, et al. Among authors: maturi rk. Clin Ophthalmol. 2023 May 11;17:1367-1384. doi: 10.2147/OPTH.S405994. eCollection 2023. Clin Ophthalmol. 2023. PMID: 37197577 Free PMC article. Clinical Trial.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
80 results